U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 34

1.
CMTM6 as a master regulator of PD-L1
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani
Cancer Immunol Immunother. 2022 Oct; 71(10): 2325–2340. Published online 2022 Mar 16. doi: 10.1007/s00262-022-03171-y
PMCID:
PMC10991181
AbstractArticlePDF–1.2M
2.
OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway
Xin Pang, Sha-sha Wang, Mei Zhang, Jian Jiang, Hua-yang Fan, Jia-shun Wu, Hao-fan Wang, Xin-hua Liang, Ya-ling Tang
Cancer Immunol Immunother. 2021 Apr; 70(4): 1015–1029. Published online 2020 Oct 26. doi: 10.1007/s00262-020-02741-2
Correction in:
Cancer Immunol Immunother. 2022 Feb; 71(2): 505–506.
PMCID:
PMC10991130
AbstractArticlePDF–20M
3.
Transmembrane Protein CMTM6 Alleviates Ocular Inflammatory Response and Improves Corneal Epithelial Barrier Function in Experimental Dry Eye
Yifan Zhou, Baikai Ma, Qiyao Liu, Hongyu Duan, Yangbo Huo, Lu Zhao, Jiawei Chen, Wenling Han, Hong Qi
Invest Ophthalmol Vis Sci. 2024 Jan; 65(1): 4. Published online 2024 Jan 2. doi: 10.1167/iovs.65.1.4
PMCID:
PMC10768713
AbstractArticlePDF–5.8M
4.
TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing
Engin Demirdizen, Ruslan Al-Ali, Ashwin Narayanan, Xueyuan Sun, Julianna Patricia Varga, Bianca Steffl, Manuela Brom, Damir Krunic, Claudia Schmidt, Gabriele Schmidt, Felix Bestvater, Julian Taranda, Şevin Turcan
Neuro Oncol. 2023 Jun; 25(6): 1031–1043. Published online 2022 Nov 22. doi: 10.1093/neuonc/noac233
PMCID:
PMC10237422
AbstractArticlePDF–23M
5.
CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
Daqi Jia, Li Xiong, Honggang Xue, Jidong Li
PeerJ. 2023; 11: e14668. Published online 2023 Jan 10. doi: 10.7717/peerj.14668
PMCID:
PMC9838204
AbstractArticlePDF–15M
6.
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu
Mol Cancer. 2023; 22: 6. Published online 2023 Jan 10. doi: 10.1186/s12943-023-01716-y
Correction in:
Mol Cancer. 2024; 23: 3.
PMCID:
PMC9830830
AbstractArticlePDF–12M
7.
Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
Hui Xue, Bin Qiu, Hao Wang, Ping Jiang, Weiwei Zhang, Lixiang Xue, Junjie Wang
Acta Biochim Biophys Sin (Shanghai) 2022 Aug; 54(8): 1193–1196. Published online 2022 Aug 15. doi: 10.3724/abbs.2022108
PMCID:
PMC9827989
ArticlePDF–1.3M
8.
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
Tong Zhang, Haixiang Yu, Xiangpeng Dai, Xiaoling Zhang
Front Immunol. 2022; 13: 971428. Published online 2022 Jul 25. doi: 10.3389/fimmu.2022.971428
PMCID:
PMC9359082
AbstractArticlePDF–2.5M
9.
A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins
Danielle G. May, Laura Martin-Sancho, Valesca Anschau, Sophie Liu, Rachel J. Chrisopulos, Kelsey L. Scott, Charles T. Halfmann, Ramon Díaz Peña, Dexter Pratt, Alexandre R. Campos, Kyle J. Roux
Viruses. 2022 Mar; 14(3): 611. Published online 2022 Mar 15. doi: 10.3390/v14030611
PMCID:
PMC8951556
AbstractArticlePDF–4.4M
10.
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Yue Huang, Yingqin Zhu, Jieying Yang, Qiuzhong Pan, Jingjing Zhao, Mengjia Song, Chaopin Yang, Yulong Han, Yan Tang, Qijing Wang, Jia He, Yongqiang Li, Junyi He, Hao Chen, Desheng Weng, Tong Xiang, Jian Chuan Xia
Cell Death Dis. 2022 Mar; 13(3): 251. Published online 2022 Mar 19. doi: 10.1038/s41419-022-04676-1
PMCID:
PMC8933468
AbstractArticlePDF–6.0M
11.
CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
Xuehui Wu, Xiaoliang Lan, Wanming Hu, Wanning Zhang, Xiangmeng Lai, Shaowan Xu, Jiaoying Li, Weihao Qiu, Wei Wang, Jianbiao Xiao, Feifei Wang, Yanqing Ding, Li Liang
Cancer Immunol Immunother. 2021 Nov; 70(11): 3235–3248. Published online 2021 Apr 5. doi: 10.1007/s00262-021-02931-6
PMCID:
PMC8505364
AbstractArticlePDF–5.6M
12.
High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence
Ryo Muranushi, Kenichiro Araki, Takehiko Yokobori, Batbayar Chingunjav, Kouki Hoshino, Gantumur Dolgormaa, Kei Hagiwara, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Yuki Shimoda, Rie Sano, Tetsunari Oyama, Hiroshi Saeki, Ken Shirabe
Cancer Sci. 2021 Aug; 112(8): 3314–3323. Published online 2021 Jun 29. doi: 10.1111/cas.15004
PMCID:
PMC8353897
AbstractArticlePDF–945K
13.
Dual Proteome-scale Networks Reveal Cell-specific Remodeling of the Human Interactome
Edward L. Huttlin, Raphael J. Bruckner, Jose Navarrete-Perea, Joe R. Cannon, Kurt Baltier, Fana Gebreab, Melanie P. Gygi, Alexandra Thornock, Gabriela Zarraga, Stanley Tam, John Szpyt, Brandon M. Gassaway, Alexandra Panov, Hannah Parzen, Sipei Fu, Arvene Golbazi, Eila Maenpaa, Keegan Stricker, Sanjukta Guha Thakurta, Tian Zhang, Ramin Rad, Joshua Pan, David P. Nusinow, Joao A. Paulo, Devin K. Schweppe, Laura Pontano Vaites, J. Wade Harper, Steven P. Gygi
Cell. Author manuscript; available in PMC 2022 May 27.
Published in final edited form as: Cell. 2021 May 27; 184(11): 3022–3040.e28. Published online 2021 May 6. doi: 10.1016/j.cell.2021.04.011
PMCID:
PMC8165030
AbstractArticlePDF–2.2M
14.
HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer
Yanbin Liu, Xingzhi Li, Hui Zhang, Mingming Zhang, Yanli Wei
Oncogene. 2021; 40(12): 2230–2242. Published online 2021 Mar 1. doi: 10.1038/s41388-021-01689-6
PMCID:
PMC7994200
AbstractArticlePDF–3.4M
15.
CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis
Pallavi Mohapatra, Omprakash Shriwas, Sibasish Mohanty, Arup Ghosh, Shuchi Smita, Sandeep Rai Kaushik, Rakesh Arya, Rachna Rath, Saroj Kumar Das Majumdar, Dillip Kumar Muduly, Sunil K. Raghav, Ranjan K. Nanda, Rupesh Dash
JCI Insight. 2021 Feb 22; 6(4): e143643. Published online 2021 Feb 22. doi: 10.1172/jci.insight.143643
PMCID:
PMC7934946
AbstractArticlePDF–4.1M
16.
Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
Li-Li Liu, Shi-Wen Zhang, Xue Chao, Chun-Hua Wang, Xia Yang, Xin-Ke Zhang, Yan-lin Wen, Jing-Ping Yun, Rong-Zhen Luo
Cancer Immunol Immunother. 2021 Feb; 70(2): 417–429. Published online 2020 Aug 7. doi: 10.1007/s00262-020-02691-9
PMCID:
PMC7889680
AbstractArticlePDF–8.1M
17.
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer
Qi-Hua Peng, Chun-Hua Wang, Hong-Min Chen, Rong-Xin Zhang, Zhi-Zhong Pan, Zhen-Hai Lu, Gao-Yuan Wang, Xin Yue, Wenlin Huang, Ran-Yi Liu
J Immunother Cancer. 2021; 9(2): e001638. Published online 2021 Feb 12. doi: 10.1136/jitc-2020-001638
PMCID:
PMC7883863
AbstractArticlePDF–3.2M
18.
CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
Kyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, Norifumi Iseda, Takahiro Tomiyama, Akinari Morinaga, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Masaki Mori
Hepatol Commun. 2021 Feb; 5(2): 334–348. Published online 2020 Nov 24. doi: 10.1002/hep4.1643
PMCID:
PMC7850307
AbstractArticlePDF–2.1M
19.
A reference map of the human binary protein interactome
Katja Luck, Dae-Kyum Kim, Luke Lambourne, Kerstin Spirohn, Bridget E. Begg, Wenting Bian, Ruth Brignall, Tiziana Cafarelli, Francisco J. Campos-Laborie, Benoit Charloteaux, Dongsic Choi, Atina G. Coté, Meaghan Daley, Steven Deimling, Alice Desbuleux, Amélie Dricot, Marinella Gebbia, Madeleine F. Hardy, Nishka Kishore, Jennifer J. Knapp, István A. Kovács, Irma Lemmens, Miles W. Mee, Joseph C. Mellor, Carl Pollis, Carles Pons, Aaron D. Richardson, Sadie Schlabach, Bridget Teeking, Anupama Yadav, Mariana Babor, Dawit Balcha, Omer Basha, Christian Bowman-Colin, Suet-Feung Chin, Soon Gang Choi, Claudia Colabella, Georges Coppin, Cassandra D’Amata, David De Ridder, Steffi De Rouck, Miquel Duran-Frigola, Hanane Ennajdaoui, Florian Goebels, Liana Goehring, Anjali Gopal, Ghazal Haddad, Elodie Hatchi, Mohamed Helmy, Yves Jacob, Yoseph Kassa, Serena Landini, Roujia Li, Natascha van Lieshout, Andrew MacWilliams, Dylan Markey, Joseph N. Paulson, Sudharshan Rangarajan, John Rasla, Ashyad Rayhan, Thomas Rolland, Adriana San-Miguel, Yun Shen, Dayag Sheykhkarimli, Gloria M. Sheynkman, Eyal Simonovsky, Murat Taşan, Alexander Tejeda, Vincent Tropepe, Jean-Claude Twizere, Yang Wang, Robert J. Weatheritt, Jochen Weile, Yu Xia, Xinping Yang, Esti Yeger-Lotem, Quan Zhong, Patrick Aloy, Gary D. Bader, Javier De Las Rivas, Suzanne Gaudet, Tong Hao, Janusz Rak, Jan Tavernier, David E. Hill, Marc Vidal, Frederick P. Roth, Michael A. Calderwood
Nature. Author manuscript; available in PMC 2020 Oct 8.
Published in final edited form as: Nature. 2020 Apr; 580(7803): 402–408. Published online 2020 Apr 8. doi: 10.1038/s41586-020-2188-x
PMCID:
PMC7169983
AbstractArticlePDF–5.4M
20.
Quantitative assessment of CMTM6 in the tumor microenvironment and association with response to PD-1 pathway blockade in advanced-stage non-small-cell lung cancer
Jon Zugazagoitia, Yuting Liu, Maria Toki, John McGuire, Fahad Shabbir Ahmed, Brian S. Henick, Richa Gupta, Scott Gettinger, Roy Herbst, Kurt A. Schalper, David L. Rimm
J Thorac Oncol. Author manuscript; available in PMC 2020 Dec 1.
Published in final edited form as: J Thorac Oncol. 2019 Dec; 14(12): 2084–2096. Published online 2019 Oct 9. doi: 10.1016/j.jtho.2019.09.014
PMCID:
PMC6951804
AbstractArticlePDF–1.5M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center